Want to buy for someone else? You can purchase a token at check out.
Overview
Many people suffer from illnesses that are treated with controlled substances. Severe chronic pain can deeply affect function and quality of life. Clinicians face a difficult task of appropriate management in improving symptoms, function, and quality of life while at the same time minimizing adverse effects, addiction, and overall safety of their patients. Long-term treatment with controlled substances can lead to adverse effects making it imperative that clinicians can recognize signs of these, along with misuse and abuse. Reviewing national and state guidelines regarding responsible treatment of controlled substances is vital to all clinicians who prescribe these medications. Many state licensing boards have already or will require healthcare professionals to complete mandated courses pertaining to controlled substances. This course will teach healthcare providers the most current guidelines on safe and responsible treatment of chronic illness with controlled substances.
Goals and Learning Outcomes
- Discuss the safe and effective management of chronic pain syndrome when prescribing opioid pain medications.
- Identify methods for monitoring patients during chronic treatment with controlled substances who are at risk for or suffering from substance use disorder.
- Learn about managing substance use disorder, including opioid weaning protocols and medication-assisted treatment.
- Describe the importance of multidisciplinary communication in identification and treatment of substance abuse and misuse.
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.